Clinical Trial Update: Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease [NA]

View source ↗

Summary

Clinical trial evaluating magnesium oral supplementation to reduce pain in inpatients with severe peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Peripheral Arterial Disease | NA | Status: UNKNOWN